U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
170521170521Treatment of Insomnia in Patients With Parkinson's Disease: A Multi-site, Placebo-controlled Study of EszopicloneCompletedHas ResultsParkinson's Disease|InsomniaDrug: eszopiclone|Other: placebohttps://ClinicalTrials.gov/show/NCT00324896
170522170522Urine Chloride/Creatinine Ratio for Estimation of Urine SodiumCompletedNo Results AvailableHypertensionhttps://ClinicalTrials.gov/show/NCT00324883
170523170523Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney CancerCompletedHas ResultsClear Cell Renal Cell Carcinoma|Recurrent Renal Cell Cancer|Stage III Renal Cell Cancer|Stage IV Renal Cell CancerDrug: vorinostat|Drug: bevacizumabhttps://ClinicalTrials.gov/show/NCT00324870
170524170524Educational Intervention for Knee PainCompletedNo Results AvailableOsteoarthritisBehavioral: Decision Aid Video|Behavioral: Motivational Interviewinghttps://ClinicalTrials.gov/show/NCT00324857
170525170525GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell LymphomaSuspendedNo Results AvailableLymphomaDrug: autologous immunoglobulin idiotype-KLH conjugate vaccine|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: prednisone|Drug: rituximab|Drug: sargramostim|Drug: vincristine|Procedure: Intervention/procedure|Procedure: antibody therapy|Procedure: biological therapy|Procedure: chemotherapy|Procedure: colony-stimulating factor therapy|Procedure: cytokine therapy|Procedure: monoclonal antibody therapy|Procedure: non-specific immune-modulator therapy|Procedure: therapeutic procedure|Procedure: tumor cell derivative vaccine|Procedure: vaccine therapyhttps://ClinicalTrials.gov/show/NCT00324831
170526170526Treatment of Bacterial VaginosisCompletedNo Results AvailableBacterial VaginosisDrug: metronidazole and azithromycinhttps://ClinicalTrials.gov/show/NCT00324818
170527170527Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By SurgeryActive, not recruitingNo Results AvailableStage IB Non-Small Cell Lung Carcinoma|Stage IIA Non-Small Cell Lung Carcinoma|Stage IIB Non-Small Cell Lung Carcinoma|Stage IIIA Non-Small Cell Lung CancerBiological: Bevacizumab|Drug: Cisplatin|Drug: Docetaxel|Drug: Gemcitabine Hydrochloride|Other: Laboratory Biomarker Analysis|Drug: Pemetrexed Disodium|Other: Questionnaire Administration|Drug: Vinorelbine Tartratehttps://ClinicalTrials.gov/show/NCT00324805
170528170528I3LTE4: Intensive Insulin Therapy and Production of LTE4 in Patients With DiabetesCompletedNo Results AvailableDiabetes Mellitus|LeucotrienesDrug: intensive insulin therapyhttps://ClinicalTrials.gov/show/NCT00324792
170529170529Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic LeukemiaCompletedNo Results AvailableLeukemia|LymphomaBiological: rituximabhttps://ClinicalTrials.gov/show/NCT00324779
170530170530Levosimendan in Acute Heart Failure Following Acute Myocardial Infarction.CompletedNo Results AvailableMyocardial Infarction|Heart Failure|Cardiogenic ShockDrug: levosimendan|Drug: placebo,https://ClinicalTrials.gov/show/NCT00324766
170531170531Quality Improvement of Patient-Provider Communication For Colorectal Cancer ScreeningCompletedNo Results AvailableColorectal CancerBehavioral: Communication|Behavioral: Standard of carehttps://ClinicalTrials.gov/show/NCT00324753
170532170532Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney CancerCompletedNo Results AvailableRecurrent Renal Cell Cancer|Stage III Renal Cell Cancer|Stage IV Renal Cell CancerDrug: vorinostat|Drug: isotretinoin|Other: pharmacological study|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00324740
170533170533Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to MelanomaCompletedNo Results AvailableIntraocular Melanoma|Melanoma (Skin)|Metastatic CancerDrug: melphalan|Drug: regional chemotherapy|Drug: systemic chemotherapy|Procedure: hepatic artery embolizationhttps://ClinicalTrials.gov/show/NCT00324727
170534170534Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCISWithdrawnNo Results AvailableBreast Cancer|OsteoporosisDrug: risedronate sodium|Other: diagnostic laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00324714
170535170535Telepsychology-Service Delivery for Depressed Elderly VeteransCompletedHas ResultsDepression|ElderlyBehavioral: Telepsychology|Behavioral: Face-to-face therapyhttps://ClinicalTrials.gov/show/NCT00324701
170536170536Safety Study of Once a Day ART and Opiate Substitute.CompletedNo Results AvailableHIV InfectionsDrug: Vireadhttps://ClinicalTrials.gov/show/NCT00324688
170537170537Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic NephropathyCompletedHas ResultsType 2 Diabetes|Overt Diabetic NephropathyDrug: Rosiglitazone|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00324675
170538170538Study to Verify Proper Detection of Supraventricular Tachyarrhythmia With Single-Lead Dual-Chamber Implantable Cardioverter-Defibrillators (ADRIA)CompletedNo Results AvailableTachyarrhythmiaDevice: Implantable cardioverter-defibrillatorhttps://ClinicalTrials.gov/show/NCT00324662
170539170539Peripheral Body Fat Distribution After Switching Zidovudine and Lamivudine to TruvadaCompletedHas ResultsHIV-1Drug: Truvada|Drug: Zidovudine/lamivudinehttps://ClinicalTrials.gov/show/NCT00324649
170540170540Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy in Patients With Metastatic MelanomaCompletedNo Results AvailableMelanoma (Skin)Biological: Melan-A VLP vaccine, IMP321 adjuvant|Biological: adoptive immunotherapy|Biological: therapeutic autologous lymphocytes|Drug: cyclophosphamide|Drug: fludarabine phosphatehttps://ClinicalTrials.gov/show/NCT00324623
170541170541Tolerance and Pharmacokinetics With Capecitabine 5 Out of 7 Days RegimenRecruitingNo Results AvailableBreast Neoplasms|ChemotherapyDrug: capecitabinehttps://ClinicalTrials.gov/show/NCT00324610
170542170542AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaActive, not recruitingNo Results AvailableLung Cancer|Lymphoma|Lymphoproliferative Disorder|Unspecified Adult Solid Tumor, Protocol SpecificDrug: gemcitabine hydrochloride|Drug: motesanib diphosphate|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00324597
170543170543Web-Based Follow-Up Using Cellular Phone in Type 1 Diabetic Patients Under Insulin Pump Therapy : The PumpNet StudyCompletedNo Results AvailableType 1 Diabetes MellitusDevice: Telemonitoring of glucose values using GlucoNet devicehttps://ClinicalTrials.gov/show/NCT00324584
170544170544Dialysis Clinical Outcomes Revisited (DCOR) TrialCompletedNo Results AvailableChronic Kidney DiseaseDrug: Sevelamer hydrochloride|Drug: Calcium-based phosphate binderhttps://ClinicalTrials.gov/show/NCT00324571
170545170545Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY)TerminatedNo Results AvailableCarcinoma, Small CellDrug: Bemiparinhttps://ClinicalTrials.gov/show/NCT00324558
170546170546Cardiovascular Outcomes Of Diet CounselingCompletedNo Results AvailableCoronary Artery Disease|ObesityBehavioral: Medium-intensity Minimally-directive Counselinghttps://ClinicalTrials.gov/show/NCT00324545
170547170547to Assess the Efficacy and Safety of the Probiotic E. Coli Strain M17 on Patients With GERDCompletedNo Results AvailableGERDDrug: ProBactrixhttps://ClinicalTrials.gov/show/NCT00324532
170548170548Randomized Trial Comparing Misoprostol and Foley Bulb for Pregnancy Termination in the Second TrimesterCompletedNo Results AvailablePregnancy Trimester, Second|Induced AbortionDevice: Foley bulb|Drug: misoprostolhttps://ClinicalTrials.gov/show/NCT00324519
170549170549Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple SclerosisCompletedNo Results AvailableMultiple SclerosisDrug: Mycophenolate Mofetil (CellCept)https://ClinicalTrials.gov/show/NCT00324506
170550170550Musculoskeletal Function in HemophiliaActive, not recruitingNo Results AvailableHemophiliahttps://ClinicalTrials.gov/show/NCT00324493

* Görseller ve İçerik tekif hakkına sahip olabilir